Pulished Date December, 2019
ID: 9012
Share on
Share on

Global Artificial Pancreas Devices Systems Market Analysis - By Type (Control to Range, Control to Target Systems), By End User (Hospitals, Medical Centers and Others), By Region ((North America (U.S., Canada), Europe (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of EU), Asia Pacific (India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC), Latin America (Brazil, Mexico, Argentina, Chile), Middle East and Africa (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA)) - Industry Size, Share, Trends, Growth, Forecast | 2019 - 2024

Pulished: December, 2019
ID: 9012
Pages: 100

Global Artificial Pancreas Devices Systems Size & Growth (2019 - 2024)

The size of the Artificial Pancreas Devices Systems Market at a global level is expected to reach USD 2000 million by 2024, growing at a CAGR of 15.5% during the forecast period 2019 - 2024.

The artificial pancreas device is a boon for diabetic patients as they process to provide healthy pancreas by substituting endocrine functionality. The hormones insulin and glucagon are provided by islet cells in the pancreas and this allows proper functioning of the brain, liver, and kidneys.

Increasing the elderly population and the rise in a number of diabetic populations is accelerating the demand of the market. Rising awareness towards the effective treatment procedures is additionally propelling the demand of the artificial pancreas devices market.

The emergence of advanced technology and the launch of innovative products in the medical sector is creating chances for the market to grow. Increasing disposable income in urbanized areas is also one of the factors influencing the demand of the market.

However, the cost for installation and maintenance of the devices are bit expensive is restraining the demand of the market. Frequent changes in economic strategies may also impact negatively on the growth of the market.

REPORT COVERAGE

Report Metric

Details

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Analysed

By Type, End-User, Region

Regions Analysed

North America (United States and Canada), Europe (UK, Spain, Germany, Italy, France and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, New Zealand, Rest of APAC), Latin America (Brazil, Argentina, Mexico and Rest of Latin America), Middle East and Africa

Companies Analysed

Medtronic Plc, Johnson & Johnson, Insulet Corp, Tandem Diabetes Care, F. Hoffmann-La Roche Ltd, Beta Bionics, Bigfoot Biomedical Inc., Inreda Diabetic B.V., Dexcom, Inc. and Cellnovo among others.

 

This research report on the Global Artificial Pancreas Devices Systems Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

Artificial Pancreas Devices Systems Market - By Type

  • Control To Range
  • Control To Target Systems

On the basis of type, the Control to range type of systems is holding with dominant shares of the market. Increasing research institutes in the biotechnology field are bolstering the demand of the market.

Artificial Pancreas Devices Systems Market - By End User

  • Hospital
  • Medical Centers
  • Others

On the basis of end-user, Hospitals sector is witnessed in dominating the largest shares of the market. Growing investments in the construction of hospitals with new equipment are fueling the growth of the market.

Artificial Pancreas Devices Systems Market - By Region

  • North America (U.S., Canada)
  • Europe (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of EU)
  • Asia Pacific (India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC
  • Latin America (Brazil, Mexico, Argentina, Chile)
  • Middle East and Africa (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA)

Regionally, North America is accounted for the highest shares of the market with the rise in capital income in most of the countries.

The Asia Pacific and Europe are positioned next to North America in dominating the highest shares of the market by owing to the increase in the geriatric population and the adoption of advanced technologies. Middle East and Africa are anticipated to have significant growth rate in the coming years.

Key market participants dominating the Global Artificial Pancreas Devices Systems Market profiled in this report are:

  • Medtronic Plc
  • Johnson & Johnson
  • Insulet Corp
  • Tandem Diabetes Care
  • F. Hoffmann-La Roche Ltd
  • Beta Bionics
  • Bigfoot Biomedical Inc.
  • Inreda Diabetic B.V.
  • Dexcom, Inc.
  • Cellnovo
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Type
      1. Control to Range
      2. Control to Target Systems
      3. Y-o-Y Growth Analysis, By Type
      4. Market Attractiveness Analysis, By Type
      5. Market Share Analysis, By Type
    2. By End User
      1. Hospitals
      2. Medical Centers
      3. Others
      4. Y-o-Y Growth Analysis, By End User
      5. Market Attractiveness Analysis, By End User
      6. Market Share Analysis, By End User
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Type
        3. By End User
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Type
        3. By End User
      5. Market Share Analysis      
        1. By Geographical Area
        2. By Type
        3. By End User
    2. North America
      1. Introduction
      2. US
      3. Canada
    3. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
    4. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
    6. Middle East & Africa
      1. Introduction
      2. Middle East
      3. Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Medtronic Plc
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Johnson & Johnson
    3. Insulet Corp
    4. Tandem Diabetes Care
    5. F. Hoffmann-La Roche Ltd
    6. Beta Bionics
    7. Bigfoot Biomedical Inc.
    8. Inreda Diabetic B.V.
    9. Dexcom, Inc.
    10. Cellnovo
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of raw materials, by application, along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Artificial Pancreas Devices Systems Market

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample